Every 10-Q that Bunge Global SA (BG) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow BG and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BG filings page.
Bunge Global SA reported net sales of $24,041 million and net income attributable to Bunge shareholders of $678 million for the quarter ended June 30, 2026, up from $12,769 million and $354 million a year earlier. Diluted EPS was $3.47 versus $2.61. For the first half, net sales were $45,902 million and net income attributable to shareholders $746 million, compared with $24,412 million and $555 million, while diluted EPS was $3.81 versus $4.10.
Total assets reached $46,782 million at June 30, 2026, including inventories of $15,461 million and cash, cash equivalents and restricted cash of $596 million. Total debt was $15,214 million. Operating activities used $1,126 million of cash in the first half, including a $2,235 million increase in inventories and $257 million more in secured advances to suppliers.
Strategically, Bunge finalized purchase accounting for the July 2025 Viterra acquisition, recording total consideration of $10,617 million and goodwill of $2,880 million. In March 2026 it acquired certain International Flavors and Fragrances businesses for $105 million and issued $1.2 billion of new senior notes, generating net proceeds of approximately $1.19 billion. It repurchased 1,966,107 shares for $249 million under a completed program, while a new authorization permits up to $3.0 billion of additional buybacks alongside a shareholder-approved $2.88 per-share annual dividend.
Bunge Global SA reported much higher first‑quarter 2026 net sales of $21.9 billion, up from $11.6 billion a year earlier, largely reflecting the inclusion of Viterra and stronger trading volumes. Despite this, profitability declined.
Net income attributable to Bunge shareholders fell to $68 million from $201 million, with diluted EPS down to $0.35 from $1.48, as higher selling, general and administrative expenses, increased interest expense, and a $94 million net foreign exchange loss weighed on results.
Operating cash flow was a use of $541 million, compared with $285 million used in the prior‑year quarter, driven mainly by a $2.2 billion inventory build and higher margin deposits, partly offset by higher trade payables and unrealized derivative gains.
Total assets rose to $47.6 billion from $44.5 billion as of December 31, 2025, supported by larger inventories and property, plant and equipment. Total debt increased to $14.6 billion, including new $1.2 billion senior notes issued in March 2026.
The company continued integrating the July 2025 acquisition of Viterra Limited, which carried total preliminary consideration of $10.6 billion and generated $2.8 billion of goodwill. In March 2026 Bunge also closed a $105 million acquisition of certain lecithin and soy protein businesses from International Flavors and Fragrances.
Bunge expanded its trade receivables securitization program from $1.5 billion to $2.0 billion, with $1.29 billion of receivables sold and derecognized as of March 31, 2026. Readily marketable inventories increased to $13.4 billion, reflecting larger positions across soybean, softseed, tropical oils, and grain segments.
The Board authorized a new $3.0 billion share repurchase program, bringing total remaining authorization to $3.2 billion, although no shares were repurchased in the quarter. Bunge paid a quarterly cash dividend of $0.70 per share, the final installment of a $2.80 annual dividend approved in 2025, and plans to seek approval for a $2.88 per‑share distribution for the next year.
Bunge Global SA (BG) filed its Q3 2025 report, reflecting the first quarter with Viterra consolidated. Net sales were $22,155 million versus $12,908 million a year ago, while net income attributable to Bunge shareholders was $166 million versus $221 million. Diluted EPS was $0.84 versus $1.56. Gross profit increased to $1,063 million and SG&A rose to $678 million, with higher interest expense at $202 million.
Bunge closed the Viterra acquisition on July 2, 2025 for total purchase consideration of $10,617 million, including about 65.6 million Bunge registered shares valued at $5,340 million and $1,880 million in cash; sellers now own approximately 33% of Bunge’s registered shares. Total assets rose to $46,298 million from $24,899 million at year-end, and long-term debt increased to $9,809 million with short-term debt at $4,446 million. The company completed the EU Oilseeds Divestment for cash proceeds of $483 million and sold its North America corn milling business for $470 million, recognizing a $155 million gain. Cash used in operating activities for the nine months was $503 million. Registered shares outstanding were 193,361,047 as of November 3, 2025.